 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Prescient Therapeutics Ltd. is a biopharmaceutical company. The firm engages in the discovery and development of novel immunotherapeutic products for the treatment of chronic infectious diseases and cancer. It develops immune therapeutics based upon its Co-X-Gene and fowlpox virus delivery technologies. The company was founded on May 22, 1986 and is headquartered in South Melbourne, Australia.

Current Price	$0.145
Prev Close	$0.16
Open	$0.145
Dividend Yield	N/A
50-Day Moving Average	$0.145
Beta	0.00
Avg. Volume	0.00
PE Ratio	-25.89

52-Week High	$0.16
52-Week Low	$0.055
Market Capitalization	$116.73M
EPS	-$0.0056
Price to Book	6.21
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

PSTTF Prescient Therapeutics Limited

About

Feed

Fundamentals

News